CEPI Announces Funding For COVID-19 Vaccine R&D

The Coalition for Epidemic Preparedness Innovations announced this week it is investing in an initiative to develop mRNA vaccines for mutations of COVID-19. The marks the latest COVID-19 vaccine effort by CEPI, which is a global partnership of public, private, philanthropic and civil society groups working to boost development of vaccines against emerging infectious diseases and provide equitable access to those vaccines. CEPI granted $12.5 million toward the development of multi-epitope, nanoparticle-based vaccine candidates and will be joined by an...
Article Type: 
Inside Drug Pricing Daily News
Site Name: 
InsideHealthPolicy.com
IDP Issue: 
Inside Drug Pricing - 02/28/2022
IDP Volume: 
Vol. 5, No. 9
Author: 
Gabrielle Wanneh

AHIP’s Priorities: Continue Upped ACA Credits; COVID-10 Flexibilities

The nation’s largest health insurance lobby laid out key priorities for 2022 and in a post-pandemic world in a Wednesday (Feb. 23) briefing on the state of the insurance industry, which include ensuring that the enhanced Affordable Care Act tax credits and telehealth flexibilities continue, that millions of Medicaid enrollees do not lose coverage once the redeterminations re-start, and tracking the new surprise billing law’s implementation. AHIP is also keeping a close eye on drug pricing reforms and potential changes...
Article Type: 
Daily News
Tags: 
mental-health
medicaid-expansion
ACA
corona
Site Name: 
InsideHealthPolicy.com
HEA Issue: 
Health Exchange Alert Weekly Report - 03/02/2022
HEA Volume: 
Vol. 10, No. 9
Author: 
Amy Lotven
Topics: 
ISSUE: INSIDE CMS
Health-Exchange-Alert
Coronavirus
Medicaid
Medicare

NJ Announces Record Enrollment, New SEP

Nearly 325,000 New Jerseyans signed up for Affordable Care Act coverage through the state-based exchange during the open enrollment period, a significant increase from last year, Democratic Gov. Phil Murphy and Department of Banking and Insurance Commissioner Marlene Caride announced Wednesday (Feb. 23). Officials further announced a new special enrollment period will be available for low-income residents eligible for low-cost or free coverage. Officials say a total of 324,266 residents signed up for coverage from Nov. 1 through Jan. 31,...
Article Type: 
Daily News
Tags: 
enrollment
ACA
Site Name: 
InsideHealthPolicy.com
HEA Issue: 
Health Exchange Alert Weekly Report - 03/02/2022
HEA Volume: 
Vol. 10, No. 9
Author: 
Amy Lotven
Topics: 
ISSUE: INSIDE CMS
Health-Exchange-Alert
Health Reform Debate




FDA Poised To Create Criteria For Evaluating Potential Food Allergens

FDA sent a draft guidance detailing criteria for evaluating potential major allergens to the White House Office of Management and Budget, potentially signaling the agency is preparing to add additional foods to the list of major allergens. The draft guidance, titled “Evaluating the Public Health Importance of Food Allergens Other Than the Major Food Allergens Listed in the Federal Food, Drug, and Cosmetic Act,” was sent to OMB on Feb. 10 and appears to be FDA’s response to requirements laid...
Article Type: 
Daily News
Tags: 
food-safety
enforcement
nutrition
Site Name: 
InsideHealthPolicy.com
FDA Issue: 
FDA Week - 02/25/2022
FDA Volume: 
Vol. 28, No. 8
Author: 
Kelly Lienhard
Topics: 
ISSUE: FDA WEEK
Mid Day E-mail
Food Safety

P4AD Urges Against Capping Insulin Costs Without Price Controls

Patients for Affordable Drugs Now is urging Democrats against pursuing a bill by Sen. Raphael Warnock (D-GA) that would cap patients’ monthly insulin costs without also controlling prices. The bill is viewed as a way to help Warnock in his tough re-election bid. “We do not think the Senate should devote energy to passing a tiny piece of BBB that will actually just cost shift, not ultimately save people money,” according to P4ADNow. In poll after poll, a strong majority...
Article Type: 
Inside Drug Pricing Daily News
Site Name: 
InsideHealthPolicy.com
IDP Issue: 
Inside Drug Pricing - 02/28/2022
IDP Volume: 
Vol. 5, No. 9
Author: 
John Wilkerson

Pages

Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.